CEO Ming Hsieh Continues Milestone‑Driven Sales at Fulgent Genetics, Reinforcing Long‑Term Commitment Despite Market Volatility
CEO Ming Hsieh’s modest insider sales show confidence in Fulgent Genetics’ growth plans, underscoring long‑term alignment with shareholders.
4 minutes to read